OLSON PETER A enters IAMBIC THERAPEUTICS, INC. with 11.41K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 10/14/2026ACC: 0002155824-26-000003
Officer· Chief Scientific Officer
Since Oct 2026
11.41K
Baseline shares
100% direct
11.41K
Direct ownership
1 position
261.63K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned11.41K
Total
11.41K direct11.41K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 11.41K | Direct |
| Total | 11.41K | 11.41K direct |
Derivative Holdings2
Employee Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
57.05K
Shares owned
N/A
Exercise price
8.73
Expiration
—
Exercise window
—
Employee Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
204.58K
Shares owned
N/A
Exercise price
7.31
Expiration
—
Exercise window
—
Total
Underlying
261.63K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock | 8.73 | — | — | 57.05K | N/A |
| Employee Stock Option (right to buy) Direct | Common Stock | 7.31 | — | — | 204.58K | N/A |
| Total | 261.63K | 0.00 | ||||